JMP Securities analyst Matthew Carletti reiterated a Buy rating on Heritage Insurance Holdings (HRTG – Research Report) today and set a price target of $6.00. The company’s shares opened today at $3.54.
According to TipRanks, Carletti is a 2-star analyst with an average return of 0.3% and a 54.15% success rate. Carletti covers the Financial sector, focusing on stocks such as Allstate, Heritage Insurance Holdings, and Chubb.
Currently, the analyst consensus on Heritage Insurance Holdings is a Moderate Buy with an average price target of $6.25.
See today’s best-performing stocks on TipRanks >>
Based on Heritage Insurance Holdings’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $158.61 million and a GAAP net loss of $30.76 million. In comparison, last year the company earned revenue of $147.24 million and had a GAAP net loss of $5.15 million
Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of HRTG in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Heritage Insurance Holdings, Inc. engages in the writing of personal and residential premium, property, and casualty insurance policies. It offers personal residential insurance for single-family homeowners and condominium owners, rental property insurance, and commercial residential insurance. The company was founded in August 2012 and is headquartered in Clearwater, FL.
Read More on HRTG:
- Carvana Co (CVNA) Gets a Buy from JMP Securities
- Nvidia Stock Lowers Revenue Guidance; Shares Down 8.3%
- Pampa Metals Confirms Tertiary Age for Host Rock Porphyry and Native Gold-Sulphide Mineralization in Quartz-Veinlet Stockwork at the Buenavista Target (Block 4 Project)
- Nokia Corporation: Repurchase of own shares on 08.08.2022
- JMP Securities Sticks to Its Buy Rating for Karuna Therapeutics (KRTX)
